| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.41 | 9e-10 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |